Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Dec;29(6):883-903.
doi: 10.1111/jpm.12830. Epub 2022 Apr 17.

Effects of reminiscence therapy in people with dementia: A systematic review and meta-analysis

Ita Daryanti Saragih  1 , Santo Imanuel Tonapa  1   2 , Ching-Teng Yao  3 , Ice Septriani Saragih  4 , Bih-O Lee  1   5
Affiliations
Meta-Analysis

Effects of reminiscence therapy in people with dementia: A systematic review and meta-analysis

Ita Daryanti Saragih et al. J Psychiatr Ment Health Nurs. 2022 Dec.

Abstract

WHAT IS KNOWN ABOUT ON THE SUBJECT?: Alternative option was developed to improve care due to the increasing costs of care cost and the number of people diagnosed with dementia. Reminiscence therapy is a commonly implemented alternative option used in long-term care facilities. Reminiscence therapy is designed for cognitive decline that is also known as life review. WHAT THIS PAPER ADDS TO EXISTING KNOWLEDGE?: Reminiscence therapy, known as psychosocial interventions in dementia care, can be used to assist people with dementia recollect prior events, activities, and experiences in order to improve their cognitive, mood, and overall well-being. Reminiscence therapy increased cognitive function and quality of life and reduced depressive and neuropsychiatric symptoms among people with dementia. Reminiscence therapy may be considered a useful non-pharmacological intervention for people with dementia living in nursing homes or other long-term care facilities. The development of a global standard protocol for the application of reminiscence therapy may be necessary for future randomized controlled trials (RCTs). ABSTRACT: Introduction Reminiscence therapy is an alternative to pharmaceutical intervention provided during long-term care, especially for individuals with dementia. However, the effects of reminiscence therapy in dementia care remain inconclusive. Aim The goal of this study is to examine the effects of reminiscence therapy implementation in people with dementia. Design Systematic literature review and meta-analysis were conducted in accordance with the PRISMA guidelines. Methods This study searched systematically using 6 databases. The eligibility criteria included patients with dementia, applied reminiscence therapy, randomized controlled trials or quasi-experimental studies, and published in the English language. The PEDro scale was used to assess the methodological quality of the included studies. The meta-analysis was performed using a random-effects model to calculate the pooled effects of reminiscence therapy. Stata 16.0 was used for statistical analysis. Result A total of 29 studies met the eligibility criteria, including 3102 participants. Overall, reminiscence therapy increased cognitive functions and quality of life and decreased depression and neuropsychiatric symptoms. Implication for Practice Reminiscence therapy may be considered a useful non-pharmacological intervention for people with dementia living in nursing homes or other long-term care facilities. A standard protocol for reminiscence therapy may be necessary for future studies.

Keywords: meta-analysis; non-pharmacological therapy; people with dementia; reminiscence therapy.

PubMed Disclaimer

References

REFERENCES

    1. Aarsland, D., Taylor, J. P., & Weintraub, D. (2014). Psychiatric issues in cognitive impairment. Movement Disorders, 29(5), 651-662. https://doi.org/10.1002/mds.25873
    1. Akanuma, K., Meguro, K., Meguro, M., Sasaki, E., Chiba, K., Ishii, H., & Tanaka, N. (2011). Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research: Neuroimaging, 192(3), 183-187. https://doi.org/10.1016/j.pscychresns.2010.11.012
    1. Albanese, E., Bütikofer, L., Armijo-Olivo, S., Ha, C., & Egger, M. (2020). Construct validity of the Physiotherapy Evidence Database (PEDro) quality scale for randomized trials: Item response theory and factor analyses. Res Synth Methods, 11(2), 227-236. https://doi.org/10.1002/jrsm.1385
    1. Alzheimer's Disease International. (2020). Dementia statistics. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/
    1. Amieva, H., Robert, P. H., Grandoulier, A.-S., Meillon, C., De Rotrou, J., Andrieu, S., Berr, C., Desgranges, B., Dubois, B., Girtanner, C., Joël, M.-E., Lavallart, B., Nourhashemi, F., Pasquier, F., Rainfray, M., Touchon, J., Chêne, G., & Dartigues, J.-F. (2016). Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial. International Psychogeriatrics, 28(5), 707-717. https://doi.org/10.1017/S1041610215001830